Table of Content




1. Executive Summary


2. Global Antibiotic Resistance Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Antibiotic Resistance Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Antibiotic Resistance Market by Disease
3.3.1: cUTI (Complicated Urinary Tract Infections)
3.3.2: CDI (Clostridioides difficile Infection)
3.3.3: ABSSSI (Acute bacterial skin and skin structure infections)
3.3.4: HABP (Hospital-acquired bacterial pneumonia)
3.3.5: CABP (Community-acquired pneumonia)
3.3.6: cIAI (Complicated intra-abdominal infection)
3.3.7: Others


3.4: Global Antibiotic Resistance Market by Pathogen
3.4.1: E. coli
3.4.2: K. pneumoniae
3.4.3: P. aeruginosa
3.4.4: S. aureus
3.4.5: A. baumannii
3.4.6: S. pneumoniae
3.4.7: Others


3.5: Global Antibiotic Resistance Market by Distribution Channel
3.5.1: Hospital Pharmacies
3.5.2: Retail Pharmacies
3.5.3: Online Pharmacies

3.6: Global Antibiotic Resistance Market by Mechanism of Action
3.6.1: Protein Synthesis Inhibitors
3.6.2: Cell Wall Synthesis Inhibitors
3.6.3: RNA Synthesis Inhibitors
3.6.4: DNA Synthesis Inhibitors
3.6.5: Others


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Antibiotic Resistance Market by Region
4.2: North American Antibiotic Resistance Market
4.2.2: North American Antibiotic Resistance Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies


4.3: European Antibiotic Resistance Market
4.3.1: European Antibiotic Resistance Market by Disease: cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), and Others
4.3.2: European Antibiotic Resistance Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies


4.4: APAC Antibiotic Resistance Market
4.4.1: APAC Antibiotic Resistance Market by Disease: cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), and Others
4.4.2: APAC Antibiotic Resistance Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies


4.5: ROW Antibiotic Resistance Market
4.5.1: ROW Antibiotic Resistance Market by Disease: cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), and Others
4.5.2: ROW Antibiotic Resistance Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Antibiotic Resistance Market by Disease
6.1.2: Growth Opportunities for the Global Antibiotic Resistance Market by Pathogen
6.1.3: Growth Opportunities for the Global Antibiotic Resistance Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Antibiotic Resistance Market by Mechanism of Action
6.1.5: Growth Opportunities for the Global Antibiotic Resistance Market by Region

6.2: Emerging Trends in the Global Antibiotic Resistance Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Antibiotic Resistance Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antibiotic Resistance Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Melinta
7.2: Basilea Pharmaceutical
7.3: Tetraphase Pharmaceuticals
7.4: Theravance Biopharma
7.5: WOCKHARDT